MNBTD
MYGN icon

Moody National Bank Trust Division’s Myriad Genetics MYGN Stock Holding History

Moody National Bank Trust Division’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-173
Closed -$6K – 748
2019
Q1 		$6K Buy
+173
New +$5.27K ﹤0.01% 791

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moody National Bank Trust Division's MYGN Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Myriad Genetics (MYGN) in Q2 2019, closing a stake of 173 shares — an estimated $6K sold.

Moody National Bank Trust Division first reported a position in MYGN in Q1 2019 and held it in 1 quarter. The position peaked at $6K in Q1 2019. 235 funds tracked by Wall St. Rank hold MYGN as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Myriad Genetics position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 173 Myriad Genetics shares in Q2 2019, an estimated $6K.
  • Moody National Bank Trust Division first reported a position in Myriad Genetics in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Myriad Genetics position peaked at $6K in Q1 2019.
  • 235 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.